These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6744690)

  • 1. Investigational antiarrhythmic agents: pirmenol.
    Reiter MJ; Pritchett EL
    Clin Cardiol; 1984 Jun; 7(6):330-4. PubMed ID: 6744690
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine.
    Anderson JL; Lutz JR; Sanders SW; Nappi JM
    J Cardiovasc Pharmacol; 1983; 5(2):213-20. PubMed ID: 6188892
    [No Abstract]   [Full Text] [Related]  

  • 3. Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics.
    Hammill SC; Shand DG; Routledge PA; Hindman MC; Baker JT; Pritchett EL
    Circulation; 1982 Feb; 65(2):369-75. PubMed ID: 7053896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and pharmacokinetics of a concentration-maintaining regimen of intravenous pirmenol.
    Reiter MJ; Hammill SC; Shand DG; Verghese C; McCarthy E; Pritchett EL
    Am J Cardiol; 1983 Jul; 52(1):83-7. PubMed ID: 6858934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of pirmenol, a new antiarrhythmic agent, assessed noninvasively.
    Toivonen LK; Nieminen MS
    Int J Cardiol; 1986 Feb; 10(2):111-8. PubMed ID: 3943931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Sugiyama A
    Jpn J Pharmacol; 1988 Oct; 48(2):273-82. PubMed ID: 3210450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation of the kinetics of pirmenol to its antiarrhythmic efficacy.
    Johnson BF; Haffajee CI; Woodman T; Sloan KL
    J Clin Pharmacol; 1988 May; 28(5):401-5. PubMed ID: 3392237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 9. Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine.
    Salerno DM; Fifield J; Farmer C; Hodges M
    Clin Cardiol; 1991 Jan; 14(1):25-32. PubMed ID: 2019027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy. Flecainide.
    Roden DM; Woosley RL
    N Engl J Med; 1986 Jul; 315(1):36-41. PubMed ID: 3520324
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacology and pharmacokinetics of pirmenol.
    Reiter MJ
    Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antiarrhythmic agents.
    Pepper GA
    Nurse Pract; 1986 Jul; 11(7):62-4, 67, 70. PubMed ID: 3737022
    [No Abstract]   [Full Text] [Related]  

  • 14. Flecainide: a new antiarrhythmic drug.
    Med Lett Drugs Ther; 1986 Feb; 28(707):19-20. PubMed ID: 3951388
    [No Abstract]   [Full Text] [Related]  

  • 15. Pirmenol: preclinical pharmacology.
    Kaplan HR; Mertz TE; Steffe TJ
    Angiology; 1988 Mar; 39(3 Pt 2):281-92. PubMed ID: 3281517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study.
    Toivonen LK; Nieminen MS; Manninen V; Frick MH
    Br Heart J; 1986 Feb; 55(2):176-80. PubMed ID: 3510642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary study of pirmenol in the treatment of ventricular arrhythmias.
    Gimeno Gascon JV; Algarra Vidal FJ
    Am J Cardiol; 1987 Jun; 59(16):53H. PubMed ID: 3591713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacology of pirmenol.
    Kaplan HR; Mertz TE; Steffe TJ
    Am J Cardiol; 1987 Jun; 59(16):2H-9H. PubMed ID: 3591710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and efficacy of pirmenol hydrochloride in the treatment of ventricular dysrhythmia.
    Lee TG; Goldberg AD; Chang T; Serkland MT; Yakatan GJ; Johnson EL; Toole JG; Goldstein S
    J Cardiovasc Pharmacol; 1983; 5(4):632-7. PubMed ID: 6193362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics and pharmacokinetics of oral pirmenol.
    Ellenbogen KA; Roark SF; Sintetos AL; Smith MS; McCarthy EA; Smith WM; Kates RE; Pritchett EL
    Clin Pharmacol Ther; 1987 Oct; 42(4):405-10. PubMed ID: 3665339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.